Mast cells enhance eosinophil survival in vitro: Role of TNF-α and granulocyte-macrophage colony-stimulating factor

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5554-5562

  Levi Schaffer, Francesca ^a   Temkin, Vladislav ^a   Malamud, Vivian ^a   Feld, Sari ^a   Zilberman, Yael ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; LIPOCORTIN 5; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALLERGY; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT;

ADOLESCENT; ADULT; ANIMALS; ANNEXIN A5; APOPTOSIS; AUTOCRINE COMMUNICATION; CELL SURVIVAL; CELL-FREE SYSTEM; CELLS, CULTURED; DRUG STABILITY; EOSINOPHILS; ERYTHROPOIETIN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAT; HISTAMINE; HUMANS; INTERLEUKIN-3; INTERLEUKIN-5; MALE; MAST CELLS; MIDDLE AGED; PROPIDIUM; PROTEIN BINDING; RATS; SONICATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032104031     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. O'Donnell, M. C. 1983. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J. Exp. Med. 157:1981.
2. Zheutlin, L. M. 1984. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J. Immunol. 133:2180.
3. Chi, E. Y., and W. R. Henderson. 1984. Ultrastructure of mast cells degranulation induced by eosinophil peroxidase: use of diaminobenzidine cytochemistry by scanning electron microscopy. J. Histochem. Cytochem. 32:337.
4. Pincus, S. H., A. M. DiNapoli, and W. R. Schooley. 1982. Superoxide production by eosinophils: activation by histamine. J. Invest. Dermatol. 79:53.
5. Anwar, A. R. E., and A. B. Kay. 1978. Enhancement of human eosinophil complement receptors by pharmacologic mediators. J. Immunol. 121:1245.
6. Dugas, B., M. Arrock, W. Czarlewski, and J. Bousquet. 1994. Activation of membrane markers from purified human eosinophils by histamine. J. Allergy Clin. Immunol. 93:167.
7. 2 and histamine activate human eosinophils. J. Immunol. 148:3536.
8. Beil, W. Y., G. R. Login, S. Y. Galli, and S. M. Dvorak. 1994. Ultrastructural immunogold localization of tumor necrosis factor α to the cytoplasmic granules of rat peritoneal mast cells with rapid microwave fixation. J. Allergy Clin. Immunol. 94(3 Part 1):531.
9. Valerius, T., R. Repp, R. Jochen, J. R. Kalden, and E. Platzer. 1990. Effects of IFN on human eosinophils in comparison with other cytokines: a novel class of eosinophil activators with delayed onset of action. J. Immunol. 145:2950.
10. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64.
11. Wodnar-Filipowicz, A., H. Heusser, and C. Moroni. 1989. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 339:150.
12. Rothenberg, M. E., W. F. Owen, and D. S. Silberstein. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3. J. Clin. Invest. 81:1986.
13. Clutterbuck, E. J., and C. J. Sanderson. 1988. Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL-5): production of functionally active eosinophils from normal human bone marrow. Blood 71:646.
14. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamua, M. Torisu, S. Mita, A. Tominaga, K. Takatsu, and T. Suda. 1988. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 is an eosinophil chemotactic factor. J. Exp. Med. 167:1737.
15. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J. Clin. Invest. 78:1220.
16. Stern, M., L. Measer, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 1418:3543.
17. Savill, J. 1994. Apoptosis in disease. Eur. J. Clin. Invest. 24:715.
18. Yousefi, S., K. Blaser, and H.-U. Simon. 1997. Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. Int. Arch. Allergy Immunol. 112:9.
19. Walsh, G. M., M. L. Williamson, F. A. Symon, G. B. Williams, and A. Wardlaw. 1996. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood 87:2815.
20. Matsumoto, K., R. P. Schleimer, H. Saito, Y. Iikway, and B. S. Bochner. 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437.
21. Hebestreti, H., S. Yousefi, I. Balatti, M. Weber, R. Crameri, D. Simon, K. Hartung, A. Schapowal, K. Blaser, and H.-U. Simon. 1996. Expression and function of the Fas receptor on human Wood and tissue eosinophils. Eur. J. Immunol. 26:1775.
22. Drvilhe, A., Z. Cai, S. Hailé, S. Chovaib, and M. Pretolani. 1996. Fas-mediated apoptosis in cultured human eosinophils. Blood 87:2822.
23. Simon, H.-U., and K. Blaser. 1995. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol. Today 16:53.
24. Simon, H.-U. 1997. Molecular mechanisms of defective eosinophil apoptosis in diseases associated with eosinophilia. Int. Arch. Allergy 113:206.
25. Woolley, K. L., P. G. Gibson, K. Carty, A. S. Wilson, S. H. Twaddell, and M. J. Woolley. 1996. Eosinophils apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154:237.
26. Hansel, T. T., I. J. M. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blazer, and S. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145:105.
27. Levi-Schaffer, F., and N. Riesel-Yaron. 1990. Effects of prolonged incubation of rat peritoneal mast cells with compound 48/80. Eur. J. Immunol. 20:2609.
28. Shaff, R. E., and M. A. Beaven. 1979. Increased sensitivity of the enzymatic isotopic assay of histamine: measurement of histamine in plasma and serum. Anal. Biochem. 94:425.
29. Vermes. I., C. Haanen, H. Steffens-Nakken, and C. Reutelingspeyer. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184:39.
30. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal. Biochem. 162:156.
31. Horie, S., and H. Kita. 1994. CD11b/CD18 (MAC-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet activating factor. J. Immunol. 152:5457.
32. White, S. R., G. V. P. Kulp, S. M. Spaethe, E. Van Alstyne, and A. R. Leff. 1991. A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophils conditioned media. J. Immunol. Methods 44:257.
33. Van Wauwe, J., F. Aerts, H. Walter, and M. de-Boer. 1995. Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors. Inflamm. Res. 44:400.
34. 3, but not cyclosporine A, inhibit production of granulocyte-macrophage colony-stimulating factor in human fibroblasts. Blood 77:1912.
35. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesizeo tumor necrosis factor alpha (TNFα)/cachectin by mouse mast cells stimulated via the Fc epison RI: a mechanism for the sustained action of mast cell-derived TNFα during IgE-dependent biological responses. J. Exp. Med. 174:103.
36. DeMonchy, J. G. R., H. F. Kauffman, P. Benge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. De Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373.
37. Yamaguchi, Y., T. Suda, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara. 1991. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542.
38. Leiferman, K. M. 1991. A current perspective on the role of eosinophils in dermatologie diseases. J. Am. Acad. Dermatol. 24:1101.
39. Lozewicz, S., E. Gomez, S. Chalstrey, D. Gatland, and R. J. Davies. 1991. Time course of cellular infiltration in the nasal mucosa during the immediate allergic reaction. Int. Arch. Allergy Appl. Immunol. 95:273.
40. Her, E., J. Frazer, K. F. Austen, and W. F. Owen. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J. Clin. Invest. 88:1982.
41. Anwar, A. R. F., R. Moqbel, G. M. Walsh, A. B. Kay, and A. J. Wardlaw. 1993. Adhesion to fibronectin prolongs eosinophil survival. J. Exp. Med. 177:839.
42. Luttmann, W., B. Knowchel, M. Foerster, H. Matthys, and J. C. Virchow, Jr., and C. Kroegel. 1996. Activation of human eosinophils by IL-13: induction of CD60 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J. Immunol. 157:1678.
43. Zeck-Kapp, G., W. Czech, and A. Kapp. 1994. TNF alpha-induced activation of eosinophil oxidative metabolism and morphology: comparison with IL-5. Exp. Dermatol. 3:176.
44. Ochiai, K., G. Matsuyama, C. Ishibara, N. Koya, and H. Tomioka. 1997. Different expression of tumor necrosis factor alpha receptor (TNFαR) on human peripheral eosinophils. Allergy Clin. Immunol. Int. (Suppl. 4):A73:21.
45. Alam, R., P. Forsythe, S. Stafford, and Y. Fukuda. 1994. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J. Exp. Med. 179:1041.
46. Owen, W. F., M. E. Rothenberg, and D. S. Silberstein. 1987. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166:129.
47. Moqbel, R., Q. Hamid, and S. Ying. 1991. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J. Exp. Med. 174:749.
48. Kita, H., T. Ohnishi, Y. Okubo, D. Weiler, Y. S. Abrams, and G. Y. Gleich. 1991. Granulocyte-macrophage colony-stimulating factor and interleukin-3 from human peripheral blood eosinophils and neutrophils. J. Exp. Med. 174:745.
49. Levi-Schaffer, F., P. Lacy, N. J. Severs, T. M. Newman, J. North, B. Gomperts, A. B. Kay, and R. Moqbel. 1995. Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 85:2579.
50. Fujisawa, T., S. Fukuda, Y. Atsuta, R. Ichimi, H. Kamiya, and M. Sakurai. 1994. Interferon-gamma induces interleukin-3 release from peripheral blood eosinophils. Int. Arch. Allergy Immunol. 104(Suppl. 1):41.
51. Takanasi, S., R. Nonaka, Z. Xing, P. O'Byrne, J. Dolovich, and M. Jordana. 1994. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180:711.